ClinicalTrials.Veeva

Menu

Genetic and Immunologic Basis of COVID-19 Infection

M

Mansoura University

Status

Completed

Conditions

Genetic Basis of COVID-19 Infection

Treatments

Diagnostic Test: Whole Exome Sequencing

Study type

Observational

Funder types

Other

Identifiers

NCT04384250
RP:20.05.70

Details and patient eligibility

About

We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy

Enrollment

500 patients

Sex

All

Ages

1 day to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • severe COVID-19 infection

Exclusion criteria

  • Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity, Malignancy, Immunosuppressive therapy)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems